New products for Aestheticians Please contact us via our contact page - email or WhatsApp if you would like to order from the price lists below Loading your shop content
Population Limitations: As noted previously, the trials did not include elderly individuals, pregnant women, children, or those with certain medical conditions
Archived from the original on January 7, 2010
For those who cannot tolerate GLP-1 gastrointestinal effects, AOD 9604 represents an alternative approach with different trade-offs
Primary peptide: KPV at 200 to 400 mcg subcutaneously daily Support peptide: Thymosin alpha-1 at 1.6 mg subcutaneously twice weekly Implementation schedule: Pre-season (4 weeks before): Begin KPV daily and Ta1 twice weekly to stabilize mast cells and rebalance Th1/Th2 ratio before allergen exposure peaks During season: Continue both peptides at the same doses throughout the allergy season Post-season: Taper KPV over 2 weeks
By using this site, you agree to comply with all applicable laws and regulations regarding these products